Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa--successes and challenges.

Mihigo R, Torrealba CV, Coninx K, Nshimirimana D, Kieny MP, Carrasco P, Hedman L, Widdowson MA.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S22-8. doi: 10.1093/infdis/jis535.

PMID:
23169967
2.

Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.

Girard MP, Katz JM, Pervikov Y, Hombach J, Tam JS.

Vaccine. 2011 Oct 13;29(44):7579-86. doi: 10.1016/j.vaccine.2011.08.031. Epub 2011 Aug 19.

PMID:
21856358
3.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
4.

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.

Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K.

BMC Infect Dis. 2012 Mar 20;12:63. doi: 10.1186/1471-2334-12-63.

5.

Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.

Tacken MA, Jansen B, Mulder J, Visscher S, Heijnen ML, Campbell SM, Braspenning JC.

Vaccine. 2013 Jan 30;31(6):900-5. doi: 10.1016/j.vaccine.2012.12.002. Epub 2012 Dec 16.

PMID:
23246546
6.

[Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].

Ertek M, Sevencan F, Kalaycıoğlu H, Gözalan A, Simşek C, Culha G, Dorman V, Ozlü A, Arıkan F, Aktaş D, Akın L, Korukluoğlu G, Sevindi DF.

Mikrobiyol Bul. 2011 Oct;45(4):684-96. Turkish.

PMID:
22090299
7.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.

8.

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P.

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

PMID:
21075164
9.

Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.

Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA.

Vaccine. 2013 Sep 23;31(41):4662-7. doi: 10.1016/j.vaccine.2013.07.005. Epub 2013 Jul 13.

PMID:
23859843
10.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.

BMC Infect Dis. 2011 Aug 26;11:230. doi: 10.1186/1471-2334-11-230.

11.

Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.

Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D.

Vaccine. 2010 Nov 29;28(51):8157-61. doi: 10.1016/j.vaccine.2010.09.096. Epub 2010 Oct 27.

PMID:
20937310
12.

Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.

Nelson CA, France EK, Shetterly SM, Glanz JM.

Pediatr Infect Dis J. 2011 Jul;30(7):562-5. doi: 10.1097/INF.0b013e31820bb482.

PMID:
21248657
13.

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

Vaccine. 2013 Feb 6;31(8):1246-54. doi: 10.1016/j.vaccine.2012.12.015. Epub 2012 Dec 16.

PMID:
23246544
14.

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.

Chlibek R, Anca I, André F, Bakir M, Ivaskeviciene I, Mangarov A, Mészner Z, Perenovska P, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Toplak N, Usonis V.

Vaccine. 2010 May 14;28(22):3758-66. doi: 10.1016/j.vaccine.2010.03.072. Epub 2010 Apr 7.

PMID:
20380902
15.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
16.
17.

Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.

Rodríguez-Rieiro C, Esteban-Vasallo MD, Domínguez-Berjón MF, Astray-Mochales J, Iniesta-Fornies D, Barranco-Ordoñez D, Cameno-Heras M, Jiménez-García R.

Vaccine. 2011 Feb 1;29(6):1332-8. doi: 10.1016/j.vaccine.2010.10.061. Epub 2010 Dec 21.

PMID:
21182996
18.

Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Kurtis HJ, dos Santos T, Danovaro-Holliday MC, Ruiz-Matus C.

Vaccine. 2012 Jan 20;30(5):916-21. doi: 10.1016/j.vaccine.2011.11.092. Epub 2011 Dec 11.

19.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

20.

Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.

Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA.

Vaccine. 2012 Jan 20;30(5):879-85. doi: 10.1016/j.vaccine.2011.11.105. Epub 2011 Dec 9.

PMID:
22155630

Supplemental Content

Support Center